Director at Bristol Myers (NYSE: BMY) awarded deferred share units

Rhea-AI Filing Summary

Bristol Myers Squibb director Michael R. McMullen received a grant of Deferred Share Units as board compensation. On March 31, 2026, he was awarded 577.082 Deferred Share Units, with a reference price of $60.65 per unit.

Each unit will convert into one share of common stock upon settlement, which occurs when he ceases to be a director or on a future date he previously selected. After this award, he holds 15,556.771 Deferred Share Units, including deferred compensation and reinvested dividends under the 1987 Deferred Compensation Plan for Non-Employee Directors.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider McMullen Michael R.

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Deferred Share Units	577.082	$60.65	$35K

Holdings After Transaction: Deferred Share Units — 15,556.771 shares (Direct)

Footnotes (1)

1. Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors.

Key Figures

Deferred Share Units granted: 577.082 units Reference price per unit: $60.65 Total Deferred Share Units after grant: 15,556.771 units +2 more

5 metrics

Deferred Share Units granted 577.082 units Award to director on March 31, 2026

Reference price per unit $60.65 Value used for Deferred Share Unit award

Total Deferred Share Units after grant 15,556.771 units Director’s deferred holdings following the transaction

Conversion ratio 1 unit = 1 share Each Deferred Share Unit converts into one common share at settlement

Conversion/exercise price $0.00 Deferred Share Units convert to shares without additional cash payment

Key Terms

Deferred Share Units, 1987 Deferred Compensation Plan for Non-Employee Directors, deferred compensation, dividends reinvested

4 terms

Deferred Share Units financial

"Each Deferred Share Unit will be converted into a share of common stock upon settlement."

Deferred share units are promises that give an executive or director the right to receive company shares or their cash value at a future date, often when they retire or leave the company. Think of them as a paycheck held in a savings account that converts into stock later; they matter to investors because they tie pay to long-term performance, create potential future dilution of shares, and represent a delayed cash or share obligation the company must eventually fulfill.

1987 Deferred Compensation Plan for Non-Employee Directors financial

"Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors."

deferred compensation financial

"Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors."

Deferred compensation is pay that employees or executives have earned now but will receive at a later date, such as delayed bonuses, retirement benefits, or stock grants. It matters to investors because it creates future obligations and shapes incentives—like a promise to pay later that can affect a company’s reported profits, cash needs and potential stock dilution—so it helps signal how a business manages costs and retains key people.

dividends reinvested financial

"Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors."

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

McMullen Michael R.

(Last) (First) (Middle)

BRISTOL-MYERS SQUIBB COMPANY

ROUTE 206 AND PROVINCE LINE ROAD

(Street)

PRINCETON NEW JERSEY 08543

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
BRISTOL MYERS SQUIBB CO [ BMY ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/31/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Deferred Share Units	(1)	03/31/2026		A		577.082		(1)	(1)	Common Stock, $0.10 par value	577.082	$60.65	15,556.771(2)	D

Explanation of Responses:

1. Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

2. Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors.

Remarks:

	/s/ Amy Fallone, attorney-in-fact for Michael R. McMullen	04/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did Bristol Myers (BMY) director Michael R. McMullen report in this Form 4?

Michael R. McMullen reported receiving 577.082 Deferred Share Units. These units are a form of director compensation tied to Bristol Myers Squibb’s common stock, rather than an open-market stock purchase, and increase his total deferred holdings to 15,556.771 units.

How many Bristol Myers (BMY) Deferred Share Units were granted to the director?

The director was granted 577.082 Deferred Share Units. Each unit represents a right to receive one share of Bristol Myers Squibb common stock at settlement, providing equity-based compensation aligned with the company’s share price performance over time.

When will Michael R. McMullen’s Bristol Myers (BMY) Deferred Share Units settle?

The Deferred Share Units settle when he ceases to be a director or on a preselected future date. At that time, each unit converts into one share of Bristol Myers Squibb common stock, turning his deferred compensation into actual share ownership.

How many total Deferred Share Units does the Bristol Myers (BMY) director now hold?

After this award, he holds 15,556.771 Deferred Share Units. This balance includes prior deferred compensation amounts and dividends that have been reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors, all ultimately payable in common stock.

Is the Bristol Myers (BMY) director’s transaction an open-market stock purchase?

No, the transaction is a grant of Deferred Share Units as compensation. It reflects an award of equity-linked units, not a cash purchase of shares in the market, and is classified as a grant, award, or other acquisition under the reporting rules.

What plan governs the Bristol Myers (BMY) director’s Deferred Share Units?

The units are tied to the 1987 Deferred Compensation Plan for Non-Employee Directors. Under this plan, directors can defer compensation, and related dividends are reinvested, accumulating as Deferred Share Units that convert later into Bristol Myers Squibb common stock.